Serial Number | 98560183 |
Word Mark | CRESPONSE |
Filing Date | Monday, May 20, 2024 |
Status | 686 - PUBLISHED FOR OPPOSITION |
Status Date | Tuesday, April 1, 2025 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, April 1, 2025 |
Goods and Services | Diagnostic testing materials, namely, specialized biological tissue culture for medical purposes; medical diagnostic reagents and assays for testing of tissue cultures and biological cultures; medical diagnostic reagents and assays for testing of body fluids; diagnostic test reagents for medical use for testing human cancer tissue; biological preparations for diagnostic purposes for medical purposes; diagnostic agents for medical and pharmaceutical purposes; diagnostic substances for medical purposes; medical diagnostic test strips for cancer analysis; diagnostic kits comprising of medical diagnostic agents, preparations and substances for medical purposes, namely, predicting response to cancer treatment; diagnostic biomarker reagents for medical purposes; in vitro diagnostic preparations for medical use; assay samples for medical and pharmaceutical use, namely cancer research; biological tissue cultures for medical purposes |
Pseudo Mark | C RESPONSE |
Goods and Services | Medical testing for diagnostic or treatment purposes; Providing medical testing services in the field of diagnosis and treatment of cancer diseases; medical testing services for diagnostic or treatment purposes in the field of optimization of pharmaceutical treatment for cancer patients; provision of medical information in the field of cancer screening, diagnosis and treatment; health care services for treating cancer; providing medical testing services and information for diagnosis, prognosis and predictive behavior of cancer for research purposes |
Goods and Services | Laboratory testing of materials in the nature of analysis in the field of cancer testing and pathology; medical research laboratory services; scientific research for medical purposes in the area of cancerous diseases; pharmaceutical product evaluation |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Monday, May 20, 2024 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Monday, May 20, 2024 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Monday, May 20, 2024 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Curesponse Ltd. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Tel Aviv 6423906 IL |
Party Name | Curesponse Ltd. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Tel Aviv 6423906 IL |
Event Date | Event Description |
Tuesday, May 21, 2024 | NEW APPLICATION ENTERED |
Saturday, November 23, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Wednesday, December 4, 2024 | ASSIGNED TO EXAMINER |
Monday, December 23, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Monday, December 23, 2024 | NON-FINAL ACTION E-MAILED |
Monday, December 23, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Monday, December 23, 2024 | NON-FINAL ACTION WRITTEN |
Monday, February 17, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Monday, December 23, 2024 | NON-FINAL ACTION E-MAILED |
Monday, December 23, 2024 | NON-FINAL ACTION WRITTEN |
Monday, February 17, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Monday, February 17, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Friday, March 7, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, March 26, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, April 1, 2025 | PUBLISHED FOR OPPOSITION |
Tuesday, April 1, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |